Boxer Capital Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NRIX
BBA
Boxer Capital Management's NRIX Position: Q3 2026 in Review
Boxer Capital Management held its Nurix Therapeutics (NRIX) position steady in Q3 2026 at 100,000 shares worth $2.37M. The position accounts for 0.21% of the portfolio, ranked #41.
Boxer Capital Management first reported a position in NRIX in Q4 2024 and has held it in 8 quarters since. The position peaked at $10.6M in Q4 2024. 234 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.
- Boxer Capital Management held 100,000 shares of Nurix Therapeutics worth $2.37M as of Q3 2026.
- Boxer Capital Management left its Nurix Therapeutics share count unchanged in Q3 2026.
- Nurix Therapeutics made up 0.21% of Boxer Capital Management's portfolio in Q3 2026, its #41 holding.
- Boxer Capital Management first reported a position in Nurix Therapeutics in Q4 2024 and has held it in 8 quarters since.
- Boxer Capital Management's Nurix Therapeutics position peaked at $10.6M in Q4 2024.
- 234 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.
Based on Boxer Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.